Page 26 of 32 · 745 questions tagged clinical-trials.
For reference: SURPASS-3 · hair thinning · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
The particulars: cagrilintide · survodutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The specifics, since they change the answer: TRIUMPH-3 · retatrutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…
For reference: STEP 5 · nausea · 2 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Numbers first: 12 mg · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Numbers first: STEP 1 · 1 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which is…
Conditions: PIONEER-4 · reflux · 7 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Concretely: headache · cagrilintide · REDEFINE-1. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
I have three data points across nine months, which I hope is enough to see a trend. I suspect the usual explanation for this is wrong, or at least incomplete. I am…
What I am working with: SUSTAIN-6 · reflux. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
The particulars: STEP 2 · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
The specifics, since they change the answer: SOUL · constipation · 14 mg. I want to understand what this actually establishes, as opposed to what it is being used to…
Numbers first: SURMOUNT-3 · early satiety · 15 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
For reference: SURPASS-3 · hair thinning. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: survodutide · mazdutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Conditions: semaglutide · STEP 5. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
Stated plainly: constipation · semaglutide · ESSENCE. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
The particulars: tirzepatide · minus 20 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
Concretely: semaglutide · 4 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…
Stated plainly: SURPASS-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
I am asking about the pattern rather than about my own management, which is elsewhere. I understand the observation; what I do not understand is the mechanism behind…
Concretely: SURMOUNT-OSA · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
Setup, so nobody has to ask: 1 mg · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided…